<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article article-type="research-article" dtd-version="1.4" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">odmj</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">OncoDaily Medical Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">ODMJ</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">3067-6444</issn>
      <publisher>
        <publisher-name>OncoDaily Medical Journal</publisher-name>
        <publisher-loc>
          <country>US</country>
        </publisher-loc>
      </publisher>
      <self-uri xlink:href="https://oncodailyjournal.com/"/>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">8269</article-id>
      <article-id pub-id-type="doi">10.69690/ODMJ-001-1026-8269</article-id>
      <article-categories>
        <subj-group xml:lang="en" subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis</article-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7357-0392</contrib-id>
          <name name-style="western">
            <surname>Tsimafeyeu</surname>
            <given-names>Ilya</given-names>
          </name>
          <aff xml:lang="en">Bureau for Cancer Research – BUCARE, New York, USA</aff>
          <email>tsimafeyeu@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-3298-1417</contrib-id>
          <name name-style="western">
            <surname>Davydova</surname>
            <given-names>Darya</given-names>
          </name>
          <aff xml:lang="en">Kidney Cancer Patient Group, Moscow, Russia</aff>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-4025-0547</contrib-id>
          <name name-style="western">
            <surname>Bal</surname>
            <given-names>Viktoria</given-names>
          </name>
          <aff xml:lang="en">STOONCO – Psychotherapy, Moscow, Russia</aff>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>26</day>
        <month>10</month>
        <year>2026</year>
      </pub-date>
      <pub-history>
        <event event-type="received">
          <event-desc>Received: <date date-type="received" iso-8601-date="2026-05-13T00:00:00+00:00"><day>13</day><month>05</month><year>2026</year></date></event-desc>
        </event>
        <event event-type="accepted">
          <event-desc>Accepted: <date date-type="accepted" iso-8601-date="2026-09-07T00:00:00+00:00"><day>07</day><month>09</month><year>2026</year></date></event-desc>
        </event>
      </pub-history>
      <elocation-id>ODMJ-001-1026-8269</elocation-id>
      <permissions>
        <copyright-statement>Copyright (c) 2026 OncoDaily Medical Journal</copyright-statement>
        <copyright-year>2026</copyright-year>
        <copyright-holder>OncoDaily Medical Journal</copyright-holder>
      </permissions>
      <self-uri xlink:href="https://oncodailyjournal.com/10.69690/odmj-001-1026-8269/"/>
      <kwd-group xml:lang="en">
        <kwd>fear of recurrence</kwd>
        <kwd>oncology supportive care</kwd>
        <kwd>patient-reported outcomes</kwd>
        <kwd>psychosocial burden</kwd>
        <kwd>quality of life</kwd>
        <kwd>Renal cell carcinoma</kwd>
        <kwd>survivorship</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>production-ready-file-url</meta-name>
          <meta-value>
            <ext-link ext-link-type="uri" xlink:href="https://oncodailyjournal.com/pub/uploads/2026/09/odmj-001-1026-8269.pdf"/>
          </meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body/>
  <back>
    <ref-list>
      <ref id="R1">
        <mixed-citation>Rose TL, Kim WY. Renal cell carcinoma: a review. JAMA. 2024;332(12):1001-10. doi:10.1001/jama.2024.12848.</mixed-citation>
      </ref>
      <ref id="R2">
        <mixed-citation>Tsimafeyeu I, Shatkovskaya O, Krasny S, et al. Overall survival in patients with metastatic renal cell carcinoma in Russia, Kazakhstan, and Belarus: a report from the RENSUR3 registry. Cancer Rep (Hoboken). 2021;4(3):e1331. doi:10.1002/cnr2.1331.</mixed-citation>
      </ref>
      <ref id="R3">
        <mixed-citation>Kotronoulas G, de la Serna CDLR, Drury A, et al. Wellbeing status and priority concerns of patients with advanced renal cell carcinoma: results of the EONS PROMs project international online survey. Support Care Cancer. 2025;33(6):531. doi:10.1007/s00520-025-09585-5.</mixed-citation>
      </ref>
      <ref id="R4">
        <mixed-citation>Giles R, Maskens D, Bick R, et al. Patient-reported experience of diagnosis, management, and burden of renal cell carcinomas: results from a global patient survey in 43 countries. Eur Urol Open Sci. 2022;37:3-6. doi:10.1016/j.euros.2021.12.003.</mixed-citation>
      </ref>
      <ref id="R5">
        <mixed-citation>Jonasch E, Bex A, Dabestani S, et al. Emotional health concerns due to kidney cancer (KC) and unmet needs in patient support: results from the International Kidney Cancer Coalition (IKCC) Global Patient Survey (GPS) [abstract]. J Clin Oncol. 2026;44(suppl):4532.</mixed-citation>
      </ref>
      <ref id="R6">
        <mixed-citation>International Kidney Cancer Coalition. World Kidney Cancer Day 2021 [Internet]. International Kidney Cancer Coalition; 2021 [accessed 2026 Aug 11].</mixed-citation>
      </ref>
      <ref id="R7">
        <mixed-citation>Vartolomei L, Schmidinger M, Vartolomei MD, et al. Psychological distress in patients treated for renal cell carcinoma: a systematic literature review. J Clin Med. 2022;11(21):6383. doi:10.3390/jcm11216383.</mixed-citation>
      </ref>
      <ref id="R8">
        <mixed-citation>Duijn M, Yildirim H, van den Hurk C, et al. Health-related quality of life in localized and metastatic renal cell carcinoma: insights from patient-reported outcome measures. Eur Urol Open Sci. 2026;84:50-57. doi:10.1016/j.euros.2025.12.017.</mixed-citation>
      </ref>
      <ref id="R9">
        <mixed-citation>Kaidarova D, Omarova I, Kaldarbekov S, et al. Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society. Explor Target Antitumor Ther. 2026;7:1002392. doi:10.37349/etat.2026.1002392.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
